non-invasive neurotechnologies

Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine

by

Click Ther­a­peu­tics Secures $30M in Growth Cap­i­tal from K2 HealthVen­tures to Expand Oper­a­tions (press release):

Click Ther­a­peu­tics, Inc. (“Click”), a leader in Dig­i­tal Ther­a­peu­tics™ solu­tions as pre­scrip­tion med­ical treat­ments, today announced $30 mil­lion in debt financ­ing from K2 HealthVen­tures (K2HV), a health­care-focused spe­cial­ty finance com­pa­ny, to accel­er­ate com­mer­cial­iza­tion of its lead­ing smok­ing ces­sa­tion solu­tion, Click­o­tine™, and to advance its pipeline of clin­i­cal­ly-val­i­dat­ed dig­i­tal ther­a­peu­tics [Read more…] about Click Ther­a­peu­tics rais­es $30 mil­lion in debt to advance com­mer­cial­iza­tion of smok­ing ces­sa­tion app Clickotine

Studies identify key ethical concerns raised by invasive and non-invasive neurotechnologies

by

Stud­ies out­line key eth­i­cal ques­tions sur­round­ing brain-com­put­er inter­face tech (NCSU release):

Brain-com­put­er inter­face (BCI) tech­nolo­gies are no longer hypo­thet­i­cal, yet there are fun­da­men­tal aspects of the tech­nol­o­gy that remain unad­dressed by both ethi­cists and pol­i­cy-mak­ers. Two new papers address these issues by out­lin­ing the out­stand­ing eth­i­cal issues, offer­ing guid­ance for address­ing those issues, and offer­ing par­tic­u­lar insight into the field of BCI tech for cog­ni­tive enhance­ment. [Read more…] about Stud­ies iden­ti­fy key eth­i­cal con­cerns raised by inva­sive and non-inva­sive neurotechnologies

Tuesday April 28th, online: Explore strategies and tools to boost mental wellbeing during (and after) Covid-19

by

Heads-up about a very time­ly vir­tu­al event next week.

When: Tues­day, April 28th, 9am — 6pm US Pacif­ic Time (San Fran­cis­co time zone)

Where: Online

What: Find Well­be­ing Dur­ing Covid19 — Dis­cov­er 200+ Free and Dis­count­ed Tools to help you find some relief and emerge even stronger

How: Learn More and Reg­is­ter HERE

Confirmed Speakers include:

[Read more…] about Tues­day April 28th, online: Explore strate­gies and tools to boost men­tal well­be­ing dur­ing (and after) Covid-19

Fast Forward to 2040: How to prepare for the new era in brain enhancement that will change the way we think, work, and heal

by

Decades from now when our aug­ment­ed brains have enhanced our cog­ni­tive func­tion and trans­formed near­ly every aspect of our lives, many of us will look back and won­der why we didn’t do more to pre­pare for these inevitable changes. Gov­ern­ment lead­ers may grap­ple with the run­away effects of AI and brain enhance­ment on geopol­i­tics. Com­pa­nies that fail to incor­po­rate neu­rotech­nolo­gies and BCI into their oper­a­tional flow could lose sig­nif­i­cant mar­ket share and be forced to scram­ble in an attempt to regain a foothold in an indus­try they once dominated.

Work­ers who don’t heed the warn­ings to re-skill or upskill may find them­selves out of a job as entire indus­tries dis­ap­pear. Grad­u­at­ing col­lege stu­dents may dis­cov­er their field of study is no longer rel­e­vant in the busi­ness world, leav­ing them unpre­pared for the chang­ing job mar­ket. Tech inno­va­tors could be caught up in fierce com­pe­ti­tion to snap up employ­ees from a very lim­it­ed tal­ent pool, dri­ving up the cost of inno­va­tion and ham­per­ing its devel­op­ment. And every­day cit­i­zens may be wrestling with the unex­pect­ed con­se­quences of unin­ten­tion­al­ly giv­ing away the rights to their neur­al data.

Rest assured, it doesn’t have to be this way. [Read more…] about Fast For­ward to 2040: How to pre­pare for the new era in brain enhance­ment that will change the way we think, work, and heal

Will digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?

by

___

Akili Inter­ac­tive: Dig­i­tal pedi­atric ADHD ther­a­peu­tic per­forms well with or with­out accom­pa­ny­ing stim­u­lant ther­a­py (Mobi­Health News):

“Dig­i­tal ther­a­peu­tic com­pa­ny Akili Inter­ac­tive has announced the first results of an open-label, mul­ti­site pedi­atric ADHD tri­al pro­vid­ing some patients with the company’s video game-like treat­ment along­side a stim­u­lant medication.

Accord­ing to the com­pa­ny, both those who received the AKL-T01 ther­a­py with (n = 130) or with­out (n = 76) accom­pa­ny­ing stim­u­lant med­ica­tion saw sig­nif­i­cant improve­ments one month after [Read more…] about Will dig­i­tal ther­a­peu­tics com­ple­ment or replace stim­u­lant med­ica­tions to address inat­ten­tion and “silent” cog­ni­tive issues?

Neurotech seen at CES 2020: BrainCo prosthetic hand, Urgonight, Alpha-Stim X, NIRSIT Lite, Muse S and FocusFit

by

___

Brain tech is here: These gad­gets from CES 2020 rely on your brain­waves to work (CNET):

“The futur­is­tic promise of tech devices that use brain waves to improve sleep, anx­i­ety and con­cen­tra­tion — and even con­trol pros­thet­ic hands — may final­ly be com­ing to fruition, with a slew of new prod­ucts on dis­play at CES 2020 in Las Vegas. Brain tech holds great poten­tial for help­ing us under­stand and con­trol our minds from the com­fort of our homes, but sci­ence still has a long way to go.

Here are some of the coolest brain tech prod­ucts we saw at CES 2020. Some of these prod­ucts are already on the mar­ket, while some are only pro­to­types.” Con­tin­ue read­ing over at CNET

News in Context: